Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,377
Total Claims
$886K
Drug Cost
416
Beneficiaries
$2,131
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+81%
Cost per patient vs peers
$2,131 vs $1,174 avg
+38%
Brand preference vs peers
12.2% vs 8.9% avg
Brand vs Generic
Brand: 1,133 claims · $686K
Generic: 8,150 claims · $193K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Linaclotide | 73 | $80K |
| Sitagliptin Phosphate | 55 | $64K |
| Insulin Glargine,hum.Rec.Anlog | 79 | $55K |
| Fluticasone/Umeclidin/Vilanter | 46 | $43K |
| Apixaban | 51 | $41K |
| Insulin Detemir | 42 | $39K |
| Ipratropium/Albuterol Sulfate | 30 | $36K |
| Dapagliflozin Propanediol | 28 | $32K |
| Mirabegron | 26 | $25K |
| Budesonide/Formoterol Fumarate | 53 | $25K |
| Rivaroxaban | 16 | $24K |
| Sitagliptin Phos/Metformin Hcl | 26 | $21K |
| Tirzepatide | 15 | $16K |
| Insulin Detemir | 24 | $16K |
| Tiotropium Bromide | 20 | $14K |
Prescribing Profile
Patient Profile
71
Avg Age
61%
Female
1.33
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data